Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Clarity Pharmaceuticals (OTC : CLRPF) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology.
Quote
| Last: | $1.58 |
|---|---|
| Change Percent: | 5.33% |
| Open: | $1.58 |
| Close: | $1.58 |
| High: | $1.58 |
| Low: | $1.58 |
| Volume: | 1,538 |
| Last Trade Date Time: | 09/25/2026 09:35:37 am |
Stock Data
| Market Cap: | $716,346,402 |
|---|---|
| Float: | 310,779,350 |
| Insiders Ownership: | N/A |
| Institutions: | |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Country: | AU |
| City: |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Clarity Pharmaceuticals (OTC: CLRPF).
